Eli Lilly said it would raise drug prices in Europe to "make them lower" in U.S., though the actual impact on most patients ...

Kornbluth learned lessons from the Duke cancer fraud case that “have powerfully shaped my approach to leadership ever since.” ...

If you’ll be at Epic’s User Group Meeting next week, 1) I hope you get some good frozen custard or cheese curds while you’re ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

Inner speech — the internal monologue in your brain as you think about what to say — can be decoded by computers and might ...

A modified CD40 antibody shrank or eliminated tumors in six of 12 metastatic cancer patients without the side effects that ...

The Trump administration’s decision to cut nearly $500 million in federal support for the development of mRNA vaccines is ...

A handful of drug companies have formed a group to present lawmakers with research on the negative impacts of Medicare drug ...

A recent U.S. warning on use of 'march-in' rights against Harvard University seems like distant threat for pharma. Here's why ...

“None of the other science agencies in HHS — NIH, FDA, nor CDC — focus on actually improving the quality of care that ...

Can Boston stay on top in biotech? Find out on Sept 17, 6-9 p.m. EDT to explore talent shifts, funding, and Boston’s future.

The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...